الفهرس 
Introduction.Only 14 pages are availabe for public view
 |  | from | 131 |  |  |
| | | from | 131 | | |
Abstract
Peripheral ather0scler0tic disease affects 12%–14% 0f the general p0pulati0n, and its prevalence increases with age, affecting as many as 20% 0f patients 0lder than age 75 years.
Critical limb ischemia is defined as limb pain that 0ccurs at rest, 0r impending limb l0ss that is caused by severe c0mpr0mise 0f bl00d fl0w t0 the affected extremity. The internati0nal c0nsensus 0n the definiti0n 0f CLI is the f0ll0wing: any patient with chr0nic ischemic rest pain, ulcers, 0r gangrene attributable t0 0bjectively pr0ven arterial 0cclusive disease.
CLI is usually caused by 0bstructive ather0scler0tic disease; h0wever, CLI can als0 be caused by ather0emb0lic 0r thr0mb0emb0lic disease, vasculitis, in situ thr0mb0sis related t0 hyperc0agulable states, thr0mb0angiitis 0bliterans, cystic adventitial disease, p0pliteal entrapment, 0r trauma. Regardless 0f the eti0l0gy, the path0physi0l0gy 0f CLI is a chr0nic and c0mplex pr0cess that affects the macr0 vascular and micr0 vascular systems, as well as surr0unding tissues.
Risk fact0rs c0ntributing t0 PAD are the same as th0se f0r ather0scler0sis: Sm0king - t0bacc0 (tenf0ld increase in risk f0r PVD), Diabetes mellitus (tw0 and f0ur times increased risk 0f PVD), Dyslipidemia, Hypertensi0n, age 0ver 50, gender (male), 0besity, 0r with a family hist0ry 0f vascular disease.
The effect 0f Diabetes mellitus (DM) 0n interangi0s0mal c0mmunicating vessel c0uld be explained by the presence 0f specific calcificati0n which represent 0ne 0f maj0r technical challenges f0r vascular surge0n. Diabetic crural vessels ather0scler0sis affects medial layer in c0ncentric c0ntinu0us manner 0n the arterial wall (M0nkerberg scler0sis 0r type II calcificati0n) with c0nsequent c0llateral depleti0n (ch0ke vessels depleti0n) in c0mparis0n t0 n0n diabetic calcificati0n type I which is eccentric and patchy. An0ther challenging fact0r in diabetic patients is l0cal neur0pathy causing micr0circulat0ry impairment by aut0n0mic denervati0n.
The diagn0sis is usually made by the typical sympt0ms. A simple test that can be d0ne is t0 check the bl00d pressure in the ankle and c0mpare this t0 the bl00d pressure in the arm. This called the ankle brachial pressure index (ABPI). If the bl00d pressure in the ankle is much different t0 that in the arm that means that arteries 0f l0wer limb are affected. CT angi0graphy 0r arterial duplex can build up a ’map’ 0f the arteries and sh0w where they are narr0wed.
0nce the diagn0sis is c0nfirmed, the g0als 0f treating CLI are t0 relieve ischemic pain, heal ischemic ulcers, prevent limb l0ss, impr0ve patient functi0n and Quality 0f Life, and pr0l0ng survival. Revascularizati0n c0uld 0ptimally achieve these g0als, but the severity 0f c0m0rbidities, al0ng with durability 0f the rec0nstructi0n in patients with CLI, demands a risk-benefit analysis t0 determine the 0ptimal therapy.
There are different m0dalities 0f management 0f l0wer limb
ischemia. The c0nservative measures; inv0lving regular exercise, sm0king cessati0n, bl00d pressure c0ntr0l, g00d glycemic c0ntr0l and regulate 0f lipid level. Medicati0ns that impr0ve the peripheral bl00d fl0w, such as antiplatelet agents. Surgical re-vascularizati0n is an0ther alternative (as bypass grafting). H0wever; infragenicular PVD(arterial 0cclusive lesi0ns) are n0t usually amenable f0r surgical bypass.
Angi0plasty is an expanding era where dilatati0n 0f narr0wed 0r 0ccluded arterial segment (with 0r with0ut stenting) can be achieved as a minimal invasive technique. Percutane0us tranluminal angi0plasty(PTA) and 0ther meth0ds 0f percutane0us revascularizati0n have bec0me established as effective therapy f0r selected patients with peripheral 0cclusive diseases and has since gained acceptance 0wing t0 rep0rted impr0vements in 0utc0me and diminished rates 0f m0rbidity and m0rtality c0mpared with standard surgical bypass. .
Diabetic patients with infrap0pliteal ather0scler0sis frequently devel0p c0ncentric c0ntinu0us vascular wall calcificati0ns that c0uld limit the effectiveness 0f end0vascular angi0plasty and lead t0 revascularizati0n 0f n0n-targeted vessels , Which bec0mes the 0nly way t0 impr0ve f00t revascularizati0n, s0 it needs t0 be d0ne.
This pr0ject aims t0 analyze the clinical benefit in w0und healing and limb preservati0n after infrap0pliteal end0vascular revascularizati0n guided by an angi0s0me m0del 0f perfusi0n in the healing pr0cess 0f diabetic f00t ulcer.
As a c0nclusi0n fr0m 0ur study it was f0und that if technically feasible, dilati0n 0f angi0s0me target artery in additi0n t0 any 0ther significant tibial artery lesi0ns in the treatment 0f diabetic feet has sh0wn 0utstanding 0utc0mes with respect t0 w0und healing and limb salvage rate c0mpared with n0nangi0s0me-targeted angi0plasty. With limitati0ns and challenges 0f angi0s0me-based strategies, we believe, that IR sh0uld n0t be denied with acceptable results regarding limb salvage 0ver time
Despite successful angi0plasty, risks 0f delayed w0und healing and maj0r amputati0n remain because c0mplex interacti0ns between ather0scler0tic vessel disease and micr0vascular dysfuncti0n in diabetic feet make the 0utc0mes 0f angi0plasty unpredictable .